Envestnet Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Buy |
|
|||||
|
2025
Q1 | $1.97M | Buy |
|
|||||
|
2024
Q4 | $2.17M | Buy |
|
|||||
|
2024
Q3 | $1.76M | Sell |
|
|||||
|
2024
Q2 | $1.58M | Sell |
|
|||||
|
2024
Q1 | $3.01M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Sell |
|
|||||
|
2023
Q2 | $2.51M | Sell |
|
|||||
|
2023
Q1 | $2.56M | Buy |
|
|||||
|
2022
Q4 | $3.09M | Buy |
|
|||||
|
2022
Q3 | $2.67M | Buy |
|
|||||
|
2022
Q2 | $2.1M | Buy |
|
|||||
|
2022
Q1 | $2.32M | Buy |
|
|||||
|
2021
Q4 | $1.99M | Buy |
|
|||||
|
2021
Q3 | $1.46M | Buy |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2021
Q1 | $1.02M | Buy |
|
|||||
|
2020
Q4 | $349K | Buy |
|
|||||
|
2020
Q3 | $204K | Sell |
|
|||||
|
2020
Q2 | $250K | Sell |
|
|||||
|
2020
Q1 | $200K | Sell |
|
|||||
|
2019
Q4 | $387K | Sell |
|
|||||
|
2019
Q3 | $748K | Sell |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $1.35M | Buy |
|
|||||
|
2018
Q4 | $1.25M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $922K | Sell |
|
|||||
|
2018
Q1 | $743K | Sell |
|
|||||
|
2017
Q4 | $2.73M | Buy |
|
|||||
|
2017
Q3 | $2.67M | Sell |
|
|||||
|
2017
Q2 | $3.04M | Buy |
|
|||||
|
2017
Q1 | $813K | Sell |
|
|||||
|
2016
Q4 | $678K | Sell |
|
|||||
|
2016
Q3 | $723K | Sell |
|
|||||
|
2016
Q2 | $768K | Sell |
|
|||||
|
2016
Q1 | $601K | Buy |
|
|||||
|
2015
Q4 | $284K | Buy |
|
|||||
|
2015
Q3 | $267K | Buy |
|
|||||
|
2015
Q2 | $201K | Buy |
|